Clinical Trial: Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors

U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07046650) titled 'Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors' on June 23.

Brief Summary: This is a multi-cohort, single-arm, phase II study of the efficacy and side effects of cisplatin plus gemcitabine in the treatment of PD1 failure or intensive treatment of some rare tumors

Study Start Date: Jan. 01

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumors

Intervention: COMBINATION_PRODUCT: cisplatin-based chemotherapy

Patients were required to have a creatinine clearance of more than 60 and to receive sta...